N@N

SSRX, JMBA, ZIOP, GASS, ELRN, ADG Expected To Be Lower After Earnings Releases on Thursday

^{Published on 2009-11-09 09:40:08, Last Modified on 2010-12-22 17:34:05 - WOPRAI}
 

November 9, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, November 12th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and November earnings reports. 3Sbio (NASDAQ: SSRX), Jamba (NASDAQ: JMBA), ZIOPHARM Oncology (NASDAQ: ZIOP), StealthGas (NASDAQ: GASS), Elron Electronic Industries (NASDAQ: ELRN) and Allied Defense Group (NYSE: ADG) are all expected to be lower after their earnings are released Thursday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go lower after earnings are released Thursday:

Symbol Company # of Reports Quarter Release Time

SSRX 3SBio Inc. 12 quarters Q3 After

JMBA Jamba, Inc. 12 quarters Q3 After

ZIOP ZIOPHARM Oncology, Inc. 12 quarters Q3 Before

GASS StealthGas Inc. 12 quarters Q3 Before

ELRN Elron Electronic Indust November earnings Q3 Before

ADG Allied Defense Group November earnings Q3 During

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

3SBio Inc. (NASDAQ: SSRX), a biotechnology company, focuses on the research, development, manufacture, and marketing of biopharmaceutical products primarily in the Peoplea�s Republic of China. Its products are designed to address unmet medical needs in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. The companya�s principal products include EPIAO, an injectable recombinant human erythropoietin to stimulate the production of red blood cells in patients with anemia and to reduce the need for blood transfusions; and TPIAO, a recombinant human thrombopoietin product to treat chemotherapy-induced thrombocytopenia, a deficiency of platelets. 3SBio also offers protein-based therapeutics, such as Intefen, a recombinant human interferon alpha-2a product for malignancies of the lymphatic or hematopoietic system, and viral infectious diseases; and Inleusin, a recombinant human interleukin-2 product for renal cell carcinoma, metastatic melanoma, and thoratic fluid build-up caused by cancer and tuberculosis. In addition, it markets Tietai Iron Sucrose Supplement, an in-licensed product for the treatment of anemia. The companya�s product pipeline comprises Ferumoxytol, a next generation intravenous iron; a high dose (36,000 IU/vial) formulation EPIAO; and NuPIAO, a second-generation EPIAO product candidate. Its product pipeline also consists of NuLeusin, a next-generation Inleusin product candidate; TPIAO for idiopathic thrombocytopenic purpura; a human papilloma virus vaccine to prevent cervical cancer; and an anti-TNF humanized monoclonal antibody product candidate for rheumatoid arthritis and other autoimmune diseases. 3SBio sells its products through distributors to hospitals, clinics, and dialysis centers, as well as through distribution agreements with local agents. It has a development and commercialization agreement with AMAG Pharmaceuticals, Inc. for ferumoxytol. The company was founded in 1993 and is based in Shenyang, the Peoplea�s Republic of China.

Jamba, Inc. (NASDAQ: JMBA), through its subsidiary, Jamba Juice Company, owns and franchises Jamba Juice stores. The company operates as a retailer of blended-to-order fruit smoothies, squeezed-to-order juices, blended beverages, and snacks. As of December 30, 2008, it operated 729 stores comprising 511 company-owned stores and 218 franchisee-owned stores in the United States and the Bahamas. The company was founded in 1990 and is headquartered in Emeryville, California.

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), a development stage biopharmaceutical company, focuses on the development and commercialization of proprietary small molecule drug candidates that are related to cancer therapeutics. Its primary product includes Palifosfamide (Zymafos or ZIO-201), which is in phase II randomized controlled trial for the treatment of metastatic or unresectable soft tissue sarcoma as front- or second-line therapy. The companya�s products in Phase I and/or II studies include Darinaparsin (Zinapar or ZIO-101), a novel anti-mitochondrial agent for the treatment of acute promyelocytic leukemia and for various other cancers; and Indibulin (Zybulin or ZIO-301), a novel small molecular-weight tubulin polymerization inhibitor. It has collaboration agreement with Harmon Hill, LLC to provide consulting and other services related to the companya�s development and commercialization of oncology therapeutics. The company was founded in 2003 and is based in New York, New York.

StealthGas Inc. (NASDAQ: GASS), through its subsidiaries, engages in the ownership of a fleet of liquefied petroleum gas (LPG) carriers that provide international seaborne transportation services to LPG producers and users in Greece and internationally. It carries various petroleum and petrochemical gas products in liquefied form, including propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are byproducts in the production of crude oil and natural gas. The company offers its services to producers of LPG products, such as national and other independent energy companies and energy traders; and industrial users of those products. It also charters product carriers that carry refined petroleum products comprising gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals. As of June 15, 2009, StealthGas had a fleet of 39 LPG carriers with a carrying capacity of 173,499 cubic meters, as well as 2 product carriers with a capacity of 94,000 deadweight tones. The company was founded in 2004 and is based in Kifisia, Greece.

Elron Electronic Industries, Ltd. (NASDAQ: ELRN), through its subsidiaries, provides technologies primarily in the fields of medical devices, information and communications technology, semiconductors, and clean technology worldwide. The companya�s medical devices include diagnostic and therapeutic tools that are used for ophthalmology, cardiology, neurology, diabetes, urology, women's health, and gastrointestinal disorders. Its information and communications technology products and services include Internet services and solutions; Internet technologies; broadband access; airborne satellite antenna services; telecom services; and IT security services. The companya�s semiconductor products include application specific integrated circuits, process control technology, tools and related hardware, and software infrastructure. It also provides clean technology consisting of water disinfection technology, and amorphous metals based technologies designed for home and industrial heating applications. The company was founded in 1961 and is headquartered in Tel Aviv, Israel.

The Allied Defense Group, Inc. (NYSE: ADG) engages in the manufacture and sale of ammunition and ammunition related products. Its products include 90mm ammunition, 105mm tank ammunition, 120mm tank ammunition, mortar ammunition, grenades, and other ammunitions. The company also purchases and resells ammunition and ammunition related products manufactured by others, as well as provides system integration and consulting services. It sells its products to the defense departments of governments and prime contractors, as well as end users, independent distributors, and resellers worldwide. The company was formerly Allied Research Corporation changed its name to The Allied Defense Group, Inc. in 2003. The Allied Defense Group was founded in 1961 and is based in Vienna, Virginia.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641